BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26630010)

  • 1. Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions.
    Reshetnyak AV; Murray PB; Shi X; Mo ES; Mohanty J; Tome F; Bai H; Gunel M; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15862-7. PubMed ID: 26630010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-α).
    Reshetnyak AV; Mohanty J; Tomé F; Puleo DE; Plotnikov AN; Ahmed M; Kaur N; Poliakov A; Cinnaiyan AM; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2018 Aug; 115(33):8340-8345. PubMed ID: 30061385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alk and Ltk ligands are essential for iridophore development in zebrafish mediated by the receptor tyrosine kinase Ltk.
    Mo ES; Cheng Q; Reshetnyak AV; Schlessinger J; Nicoli S
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):12027-12032. PubMed ID: 29078341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase.
    Guan J; Umapathy G; Yamazaki Y; Wolfstetter G; Mendoza P; Pfeifer K; Mohammed A; Hugosson F; Zhang H; Hsu AW; Halenbeck R; Hallberg B; Palmer RH
    Elife; 2015 Sep; 4():e09811. PubMed ID: 26418745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifaceted Roles of ALK Family Receptors and Augmentor Ligands in Health and Disease: A Comprehensive Review.
    Katic L; Priscan A
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALKALs are in vivo ligands for ALK family receptor tyrosine kinases in the neural crest and derived cells.
    Fadeev A; Mendoza-Garcia P; Irion U; Guan J; Pfeifer K; Wiessner S; Serluca F; Singh AP; Nüsslein-Volhard C; Palmer RH
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E630-E638. PubMed ID: 29317532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of cytokine-mediated activation of ALK family receptors.
    De Munck S; Provost M; Kurikawa M; Omori I; Mukohyama J; Felix J; Bloch Y; Abdel-Wahab O; Bazan JF; Yoshimi A; Savvides SN
    Nature; 2021 Dec; 600(7887):143-147. PubMed ID: 34646012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome.
    Zhang H; Pao LI; Zhou A; Brace AD; Halenbeck R; Hsu AW; Bray TL; Hestir K; Bosch E; Lee E; Wang G; Liu H; Wong BR; Kavanaugh WM; Williams LT
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):15741-5. PubMed ID: 25331893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Genomics within and across Bilaterians Illuminates the Evolutionary History of ALK and LTK Proto-Oncogene Origination and Diversification.
    Dornburg A; Wang Z; Wang J; Mo ES; López-Giráldez F; Townsend JP
    Genome Biol Evol; 2021 Jan; 13(1):. PubMed ID: 33196781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaplastic lymphoma kinase L1198F and G1201E mutations identified in anaplastic thyroid cancer patients are not ligand-independent.
    Guan J; Wolfstetter G; Siaw J; Chand D; Hugosson F; Palmer RH; Hallberg B
    Oncotarget; 2017 Feb; 8(7):11566-11578. PubMed ID: 28030793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypothalamic pathway for Augmentor α-controlled body weight regulation.
    Ahmed M; Kaur N; Cheng Q; Shanabrough M; Tretiakov EO; Harkany T; Horvath TL; Schlessinger J
    Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2200476119. PubMed ID: 35412887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK.
    Murray PB; Lax I; Reshetnyak A; Ligon GF; Lillquist JS; Natoli EJ; Shi X; Folta-Stogniew E; Gunel M; Alvarado D; Schlessinger J
    Sci Signal; 2015 Jan; 8(360):ra6. PubMed ID: 25605972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALK-activating homologous mutations in LTK induce cellular transformation.
    Roll JD; Reuther GW
    PLoS One; 2012; 7(2):e31733. PubMed ID: 22347506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplastic lymphoma kinase: "Ligand Independent Activation" mediated by the PTN/RPTPβ/ζ signaling pathway.
    Deuel TF
    Biochim Biophys Acta; 2013 Oct; 1834(10):2219-23. PubMed ID: 23777859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK).
    Morris SW; Naeve C; Mathew P; James PL; Kirstein MN; Cui X; Witte DP
    Oncogene; 1997 May; 14(18):2175-88. PubMed ID: 9174053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An epidermal growth factor receptor-leukocyte tyrosine kinase chimeric receptor generates ligand-dependent growth signals through the Ras signaling pathway.
    Ueno H; Hirano N; Kozutsumi H; Sasaki K; Tanaka T; Yazaki Y; Hirai H
    J Biol Chem; 1995 Aug; 270(34):20135-42. PubMed ID: 7650032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor.
    Stylianou DC; Auf der Maur A; Kodack DP; Henke RT; Hohn S; Toretsky JA; Riegel AT; Wellstein A
    Oncogene; 2009 Sep; 28(37):3296-306. PubMed ID: 19633684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene.
    Murugan AK; Xing M
    Cancer Res; 2011 Jul; 71(13):4403-11. PubMed ID: 21596819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells.
    Piccinini G; Bacchiocchi R; Serresi M; Vivani C; Rossetti S; Gennaretti C; Carbonari D; Fazioli F
    J Biol Chem; 2002 Jun; 277(25):22231-9. PubMed ID: 11919185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
    Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.